Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rhei Pharmaceuticals Inc.

www.rheipharma.com

Latest From Rhei Pharmaceuticals Inc.

Europe's New Spec Pharma Models

Spec pharma has created significant value in the US, but not, so far, in Europe. Still, Europe's spec pharma hopefuls aren't giving up, and they're trying out variations on the theme--some starting with infrastructure, others with products.
Europe North America

Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals was founded to take ganaxolone, a problematic compound for which tantalizing human efficacy data already exists and reformulate it to overcome the pharmacokinetic and cost problems holding it back. In just two years since in-licensing it, Marinus has succeeded in reformulating the drug and putting it back into clinical testing for two epilepsy indications with hopes of building a multi-indication franchise around it.
BioPharmaceutical

Start-Up Previews (11/06)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Moving beyond Accutane and Botox", includes profiles of Magen BioSciences, Neosil, Syntopix and TransDerm. Plus these Start-Ups Across Health Care: Cardiak, Innovive Pharmaceuticals, RHEI Pharmaceuticals and ViewRay.

RHEI Pharmaceuticals Inc.

Specialty pharma RHEI Pharmaceuticals' mission is to in-license China rights to partners' approved drugs or late-stage candidates, shepherd them through regulatory approval, and launch them in the China marketplace.
BioPharmaceutical Middle East and Africa
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Rhei Pharmaceuticals Inc.
  • Senior Management
  • Geert Cauwenbergh, PhD, CEO
    Scott B Kozak, VP, Lic. & Corp. Dev.
  • Contact Info
  • Rhei Pharmaceuticals Inc.
    Phone: (203) 624-7434
    300 George St.
    Ste. 530
    New Haven, CT 06511
    USA
UsernamePublicRestriction

Register